Abstract
This review discusses progress made over the past 10+ years in elucidating the properties, regulation, and function of protein tyrosine phosphatase alpha (PTPα). It is apparent from studies in knockout mice and diverse cell lines that the major action of PTPα is as a positive regulator of src and src family kinases. PTPα dephosphorylates and activates src. In this manner it affects transformation and tumourigenesis, inhibition of proliferation and cell cycle arrest, mitotic activation of src, integrin signaling, neuronal differentiation and outgrowth, and ion channel activity. PTPα may well modulate additional processes, including insulin signaling, and have other targets besides src family kinases. As an important modulator of several specific cell signaling pathways, PTPα has promise as a target for drug discovery. Continued research on the physiological and pathological activities of PTPα is necessary to define the therapeutic potential of PTPα-directed pharmacologicals.
Keywords: Protein Tyrosine Phosphatase, tumourigenesis
Current Topics in Medicinal Chemistry
Title: Protein Tyrosine Phosphatase α (PTPα): A Src Family Kinase Activator and Mediator of Multiple Biological Effects
Volume: 3 Issue: 7
Author(s): Catherine J. Pallen
Affiliation:
Keywords: Protein Tyrosine Phosphatase, tumourigenesis
Abstract: This review discusses progress made over the past 10+ years in elucidating the properties, regulation, and function of protein tyrosine phosphatase alpha (PTPα). It is apparent from studies in knockout mice and diverse cell lines that the major action of PTPα is as a positive regulator of src and src family kinases. PTPα dephosphorylates and activates src. In this manner it affects transformation and tumourigenesis, inhibition of proliferation and cell cycle arrest, mitotic activation of src, integrin signaling, neuronal differentiation and outgrowth, and ion channel activity. PTPα may well modulate additional processes, including insulin signaling, and have other targets besides src family kinases. As an important modulator of several specific cell signaling pathways, PTPα has promise as a target for drug discovery. Continued research on the physiological and pathological activities of PTPα is necessary to define the therapeutic potential of PTPα-directed pharmacologicals.
Export Options
About this article
Cite this article as:
Pallen J. Catherine, Protein Tyrosine Phosphatase α (PTPα): A Src Family Kinase Activator and Mediator of Multiple Biological Effects, Current Topics in Medicinal Chemistry 2003; 3 (7) . https://dx.doi.org/10.2174/1568026033452320
DOI https://dx.doi.org/10.2174/1568026033452320 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Enzyme Inhibition, Kinetic, and Molecular Docking Studies of α-glucosidase
Current Enzyme Inhibition The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
CNS & Neurological Disorders - Drug Targets Deficient Phagocytosis Among HIV-1 Infected Adults Over Time Even in HAART Setting
Current HIV Research Novel Chemically Modified Bacterial Cellulose Nanocomposite as Potential Biomaterial for Stem Cell Therapy Applications
Current Stem Cell Research & Therapy Local Drug Delivery Based Treatment Approaches for Effective Management of Periodontitis
Current Drug Therapy Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design Identification of Differentially Expressed Genes Associated with Papillary Thyroid Carcinoma
Combinatorial Chemistry & High Throughput Screening Functions of S100 Proteins
Current Molecular Medicine Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes
Current Vascular Pharmacology Current Progress in Molecular Responses to Acidosis in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Editorial [ Hot Topic: The Blood-Brain Barrier as a Cause of Disease (Executive Editor: William A. Banks) ]
Current Pharmaceutical Design Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance
CNS & Neurological Disorders - Drug Targets Exploring Shared Pathogenesis of Alzheimer’s Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis
Current Alzheimer Research Anti-TSH Receptor Antibodies in the Congolese with Hyperthyroidism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial (Thematic Issue: Global Trends for Nanotechnological Approaches in Various Health Issues - Part 1)
Current Drug Metabolism Editorial (Hot Topic: New Insight into the RAMP-based Family B GPCRs and their Peptide Ligands)
Current Protein & Peptide Science The Relationship Between HIV Infection and Cardiovascular Disease
Current Cardiology Reviews